Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine Acetate Monotherapy in Partial Epilepsy
NCT00866775Phase 3Completed
- Sponsor
- Sumitomo Pharma America
- Start
- Apr 2009
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of eslicarbazepine acetate in partial epilepsy, sponsored by Sumitomo Pharma America. Started Apr 2009; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
partial epilepsy
Beyond the preview
Go deeper on NCT00866775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866775.